Brean Murray Carret & Co. Starts Pharmacyclics (PCYC) at Buy; Positive on Ibrutinib
Tweet Send to a FriendGet Alerts PCYC Hot Sheet
Price: $84.37 -1.44%
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 13
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 13
Trade PCYC Now!
Brean Murray Carret & Co. initiates coverage on Pharmacyclics (NASDAQ: PCYC) with a Buy. PT $80.00.
Analyst, Brian Skorney, said, "Initiating coverage on PCYC with a Buy primarily based on the value of the first-in-class BTK inhibitor, ibrutinib. We believe ibrutinib is one of the most attractive drugs in development, given the consistently robust clinical activity demostrated in several different hematologic malignancies. The impressive efficacy is matched by an equally impressive safety profile..."
For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.
Shares of Pharmacyclics closed at $34.77 yesterday, with a 52 week range of $7.08-$35.20.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Brian Skorney, said, "Initiating coverage on PCYC with a Buy primarily based on the value of the first-in-class BTK inhibitor, ibrutinib. We believe ibrutinib is one of the most attractive drugs in development, given the consistently robust clinical activity demostrated in several different hematologic malignancies. The impressive efficacy is matched by an equally impressive safety profile..."
For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.
Shares of Pharmacyclics closed at $34.77 yesterday, with a 52 week range of $7.08-$35.20.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Resumes CenterPoint Energy (CNP) at Hold
- Topeka Capital Starts Diodes (DIOD) at Buy
- Topeka Capital Starts InvenSense (INVN) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Brean Murray Carret & Co.
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
